Page last updated: 2024-08-21

perillyl alcohol and Breast Cancer

perillyl alcohol has been researched along with Breast Cancer in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	6 (46.15)	18.2507
2000's	5 (38.46)	29.6817
2010's	1 (7.69)	24.3611
2020's	1 (7.69)	2.80

Authors

Authors	Studies
Beringer, PM; Chen, L; Chen, TC; Cho, HY; Fu, J; He, H; Marín-Ramos, NI; Neman, J; Schönthal, AH; Swenson, SD; Wang, W; Zeng, S	1
Carper, SW; Elegbede, JA; Hall, C; Yeruva, L	1
Danbara, N; Kanzaki, H; Kiyozuka, Y; Senzaki, H; Shikata, N; Tsubura, A; Tsujita-Kyutoku, M; Yuri, T	1
Coop, A; Ellis, MJ; Gallagher, A; Hayes, DF; Lieberman, R; Pennanen, M; Singh, B; Stearns, V; Trock, B; Yamauchi, H	1
Berchtold, CM; Chen, KS; Gould, MN; Miyamoto, S	1
Chan, NL; Leung, HY; Leung, LK; Wang, H; Wang, Y	1
Attia, S; Bailey, HH; Chappell, R; Fass, T; Hansen, R; Harris, L; Jumonville, A; Love, RR; Shapiro, GR; Stewart, JA; Tutsch, K	1
O'Shaughnessy, JA	1
Burke, YD; Crowell, PL; Siar Ayoubi, A	1
Cheson, BD; Ho, P; Nelson, A; Saunders, J; Sepelak, SB; Zweibel, J	1
Bardon, S; Martel, P; Picard, K	1
Gould, MN; Miyamoto, S; Satomi, Y	1

Reviews

1 review(s) available for perillyl alcohol and Breast Cancer

Article	Year
Antitumorigenic effects of limonene and perillyl alcohol against pancreatic and breast cancer. Advances in experimental medicine and biology, 1996, Volume: 401 Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Breast Neoplasms; Cyclohexenes; Dietary Fats, Unsaturated; Drug Screening Assays, Antitumor; Humans; Limonene; Monoterpenes; Pancreatic Neoplasms; Terpenes	1996

Trials

2 trial(s) available for perillyl alcohol and Breast Cancer

Article	Year
A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasia. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Nov-15, Volume: 10, Issue:22 Topics: Aged; Antineoplastic Agents; Apoptosis; Biomarkers; Biomarkers, Tumor; Biopsy; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Intraductal, Noninfiltrating; Cell Proliferation; Cohort Studies; Female; Humans; Immunohistochemistry; Middle Aged; Monoterpenes; Pilot Projects; Time Factors; Treatment Outcome	2004
Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer. Cancer chemotherapy and pharmacology, 2008, Volume: 62, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Biotransformation; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Endpoint Determination; Female; Humans; Middle Aged; Monoterpenes; Neoplasm Metastasis; Transforming Growth Factor beta1; Treatment Outcome	2008

Article

Year

A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasia.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Nov-15, Volume: 10, Issue:22

Topics: Aged; Antineoplastic Agents; Apoptosis; Biomarkers; Biomarkers, Tumor; Biopsy; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Intraductal, Noninfiltrating; Cell Proliferation; Cohort Studies; Female; Humans; Immunohistochemistry; Middle Aged; Monoterpenes; Pilot Projects; Time Factors; Treatment Outcome

2004

Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer.

Cancer chemotherapy and pharmacology, 2008, Volume: 62, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Biotransformation; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Endpoint Determination; Female; Humans; Middle Aged; Monoterpenes; Neoplasm Metastasis; Transforming Growth Factor beta1; Treatment Outcome

2008

Other Studies

10 other study(ies) available for perillyl alcohol and Breast Cancer

Article	Year
Enhanced brain delivery and therapeutic activity of trastuzumab after blood-brain barrier opening by NEO100 in mouse models of brain-metastatic breast cancer. Neuro-oncology, 2021, 10-01, Volume: 23, Issue:10 Topics: Animals; Blood-Brain Barrier; Brain; Brain Neoplasms; Breast Neoplasms; Endothelial Cells; Female; Humans; Mice; Monoterpenes; Receptor, ErbB-2; Trastuzumab	2021
Perillyl alcohol and methyl jasmonate sensitize cancer cells to cisplatin. Anti-cancer drugs, 2010, Volume: 21, Issue:1 Topics: Acetates; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Culture Techniques; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Cyclopentanes; Drug Synergism; Female; Flow Cytometry; Humans; Membrane Potential, Mitochondrial; Monoterpenes; Oxylipins; Receptors, Tumor Necrosis Factor, Type I; Tumor Necrosis Factor-alpha; Tumor Stem Cell Assay	2010
Perillyl alcohol inhibits human breast cancer cell growth in vitro and in vivo. Breast cancer research and treatment, 2004, Volume: 84, Issue:3 Topics: Animals; Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Cell Cycle; Cyclins; Dose-Response Relationship, Drug; Female; Humans; Immunohistochemistry; Infusions, Parenteral; Mice; Mice, Nude; Monoterpenes; Neoplasm Metastasis; Proliferating Cell Nuclear Antigen; Receptors, Estrogen; Tumor Cells, Cultured	2004
Perillyl alcohol inhibits a calcium-dependent constitutive nuclear factor-kappaB pathway. Cancer research, 2005, Sep-15, Volume: 65, Issue:18 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line, Tumor; Humans; Lymphoma, B-Cell; Monoterpenes; NF-kappa B	2005
Polycyclic aromatic hydrocarbon-induced CYP1B1 activity is suppressed by perillyl alcohol in MCF-7 cells. Toxicology and applied pharmacology, 2006, Jun-01, Volume: 213, Issue:2 Topics: 9,10-Dimethyl-1,2-benzanthracene; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Breast Neoplasms; Carcinogens; Cell Line, Tumor; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; DNA Adducts; DNA Damage; Down-Regulation; Drug Interactions; Enzyme Inhibitors; Epithelial Cells; Female; Humans; Inhibitory Concentration 50; Monoterpenes; Polycyclic Aromatic Hydrocarbons; Transcriptional Activation; Xenobiotics	2006
Chemoprevention of breast cancer. JAMA, 1996, May-01, Volume: 275, Issue:17 Topics: Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Clinical Trials as Topic; Combined Modality Therapy; Cyclohexenes; Dehydroepiandrosterone; Estrogen Antagonists; Female; Genistein; Humans; Isoflavones; Limonene; Middle Aged; Monoterpenes; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Retinoids; Tamoxifen; Terpenes	1996
Clinical development plan: l-perillyl alcohol. Journal of cellular biochemistry. Supplement, 1996, Volume: 26 Topics: Animals; Anticarcinogenic Agents; Breast Neoplasms; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cricetinae; Drug Approval; Female; Humans; Male; Mice; Monoterpenes; Neoplasms, Experimental; Prostatic Neoplasms; Rats; Research Design; Terpenes; Toxicity Tests	1996
Clinical trials referral resource. Clinical trials with perillyl alcohol. Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:12 Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Male; Monoterpenes; Ovarian Neoplasms; Prostatic Neoplasms; Terpenes	1997
Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines. Nutrition and cancer, 1998, Volume: 32, Issue:1 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cell Division; Cyclin D1; Cyclohexenes; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Limonene; Monoterpenes; Terpenes; Tumor Cells, Cultured	1998
Induction of AP-1 activity by perillyl alcohol in breast cancer cells. Carcinogenesis, 1999, Volume: 20, Issue:10 Topics: Animals; Breast Neoplasms; Humans; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Monoterpenes; Phosphorylation; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Terpenes; Transcription Factor AP-1; Transcription, Genetic; Tumor Cells, Cultured	1999